Florida Atlantic University Patents
Displaying 1 - 3 of 3
Materials and Methods for the Treatment of Pathological Neovascularization in the Eye, 2012
Type: Text
Year: 2012, 2012, 2012, 2012
Member of: Florida Atlantic University Patents
Contributors: Blanks, Janet C., Prentice, Howard M.
Publisher: Florida Atlantic University
Description: The subject invention provides materials and methods useful
in safely and effectively preventing pathological proliferation
of blood vessels. The prevention of the over-proliferation of
blood vessels according to the subject invention is particularly
advantageous for treatment of certain ocular conditions
including age-related macular degeneration (AMD), retinopathy
of prematurity (ROP) and… more
Full Text: 111111 1111111111111111111111111111111111111111111111111111111111111111111111111111 US 20120077870Al United States c12) Patent Application Publication (19) Blanks et al. (54) (76) (43) Pub. Date: MATERIALS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL …
GFAP-based gene therapy for treatment of retinal diseases
Type: Text
Year: 2005, 2005
Member of: Florida Atlantic University Patents
Contributors: Blanks, Janet C., Dorey, C. Kathleen, Prentice, Howard
Full Text: Office of Technology Transfer Patents Florida Atlantic University Libraries Year GFAP-Based Gene Therapy for Treatment of Retinal Diseases C. Kathleen Dorey Janet C. Blanks Howard Prentice Florida Atlantic University snappi@fau.edu This paper is …
GFAP-Based Gene Therapy for Treatment of Retinal Diseases, 2008
Type: Text
Year: 2008, 2008, 2008, 2008
Member of: Florida Atlantic University Patents
Contributors: Blanks, Janet C., Dorey, C. Kathleen
Publisher: Florida Atlantic University
Description: Compositions and methods for reducing neovascularization.
Purified nucleic acid constructs and vectors encoding an antiangiogenic
protein operably linked to a GFAP promoter. Vectors
can include at least one hypoxia regulated element,
enhancer element and silencer element. Gene therapy methods
for reducing, delaying or preventing neovascularization
based on the nucleic acid constructs and vectors.
Full Text: 111111 1111111111111111111111111111111111111111111111111111111111111111111111111111 US 20080305083Al United States c12) Patent Application Publication (19) DOREY et al. (54) GFAP-BASED GENE THERAPY FOR TREATMENT OF RETINAL DISEASES (75) Inventors: C. …